Table 2.
Parameters | Non-GI Group (n = 17) | GI Group (n = 14) | Reference Interval | ||
---|---|---|---|---|---|
Median (range) | Prevalence of ↑/↓ | Median (range) | Prevalence of ↑/↓ | ||
ALT (U/L) | 67 (9.5–226) | ↑ 9 (50%) | 55 (20–115) | ↑ 3 (22%) | 20–70 |
ALP (U/L) | 144 (22–1175) | ↑ 4 (22%) | 108 (43–3640) | ↑ 5 (35%) | 45–250 |
GGT (U/L) | 5.3 (1.8–46.7) | ↑ 5 (27%) | 4 (1–17.2) | ↑ 1 (7%) | 2–11 |
TBIL (mg/dL) | 0.22 (0.08–0.48) | ↑ 2 (11%) | 0.16 (0.1–0.28) | ↑ 0 (0%) | 0–0.3 |
COL (mg/dL) | 448 (214–1146) | ↑ 10 (55%) | 340 (166–888) | ↑ 10 (72%) | 120–280 |
TRI (mg/dL) | 174 (58–750) | ↑ 10 (55%) | 349 (59–757) | ↑ 9 (64%) | 25–90 |
TP (g/dL) | 7 (5.6–8.3) | ↓ 1 (3%) | 6.7 (4.8–8) | ↓ 1 (7%) | 5.8–7.8 |
ALB (g/dL) | 3.2 (2.2–4) | ↓ 1 (3%) | 3.4 (2.6–4.4) | ↓ 3 (22%) | 2.6–4.1 |
ALT, alanine aminotransferase; ALP, alkaline phosphatase; COL, cholesterol; GGT, gamma-glutamyltransferase; TBIL, total bilirubin; TP, total protein; TRI, triglycerides; ALB, albumin, RI, reference interval; ↓ parameter lower than RI; ↑ parameter above the RI.